- Home
- VCEL vs SEZL Comparison
VCEL vs SEZL Comparison
Compare VCEL & SEZL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- SEZL
- Stock Information
- Founded
- VCEL 1989
- SEZL 2016
- Country
- VCEL United States
- SEZL United States
- Employees
- VCEL N/A
- SEZL N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- SEZL Diversified Financial Services
- Sector
- VCEL Health Care
- SEZL Finance
- Exchange
- VCEL Nasdaq
- SEZL Nasdaq
- Market Cap
- VCEL 2.0B
- SEZL 2.2B
- IPO Year
- VCEL 1997
- SEZL N/A
- Fundamental
- Price
- VCEL $40.79
- SEZL $58.31
- Analyst Decision
- VCEL Strong Buy
- SEZL Buy
- Analyst Count
- VCEL 6
- SEZL 4
- Target Price
- VCEL $60.40
- SEZL $113.75
- AVG Volume (30 Days)
- VCEL 694.4K
- SEZL 1.1M
- Earning Date
- VCEL 11-06-2025
- SEZL 11-05-2025
- Dividend Yield
- VCEL N/A
- SEZL N/A
- EPS Growth
- VCEL 236.54
- SEZL 104.61
- EPS
- VCEL 0.25
- SEZL 3.24
- Revenue
- VCEL $258,716,999.00
- SEZL $418,632,890.00
- Revenue This Year
- VCEL $18.35
- SEZL $65.77
- Revenue Next Year
- VCEL $22.26
- SEZL $27.29
- P/E Ratio
- VCEL $164.69
- SEZL $18.15
- Revenue Growth
- VCEL 14.05
- SEZL 88.74
- 52 Week Low
- VCEL $29.24
- SEZL $24.86
- 52 Week High
- VCEL $63.00
- SEZL $186.74
- Technical
- Relative Strength Index (RSI)
- VCEL 58.46
- SEZL 43.79
- Support Level
- VCEL $37.51
- SEZL $52.14
- Resistance Level
- VCEL $41.66
- SEZL $57.06
- Average True Range (ATR)
- VCEL 1.88
- SEZL 3.51
- MACD
- VCEL 0.04
- SEZL 1.13
- Stochastic Oscillator
- VCEL 58.37
- SEZL 63.54
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About SEZL Sezzle Inc.
Sezzle Inc is a financing institution that offers technology-driven payment platform. It allows customers to split their purchase into four installments and pay over 6 weeks with only the first payment due at the time of purchase. Companies operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.